Combined Value of Validated Clinical and Genomic Risk Stratification Tools for Predicting Prostate Cancer Mortality in a High-risk Prostatectomy Cohort-Reference-Cited by-同舟云学术

Combined Value of Validated Clinical and Genomic Risk Stratification Tools for Predicting Prostate Cancer Mortality in a High-risk Prostatectomy Cohort

Published:2015-02 Issue:2 Volume:67 Page:326-333
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Cooperberg Matthew R.,Davicioni Elai,Crisan Anamaria,Jenkins Robert B.,Ghadessi Mercedeh,Karnes R. Jeffrey

Publisher

Elsevier BV

Subject

Urology

Reference24 articles.

1. The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy;Cooperberg;Cancer,2011

2. Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy;Punnen;Eur Urol,2014

3. Biomarkers in prostate cancer surveillance and screening: past, present, and future;Cary;Ther Adv Urol,2013

4. A tissue biomarker panel predicting systemic progression after PSA recurrence post-definitive prostate cancer therapy;Nakagawa;PLoS ONE,2008

5. Analytical validation of the oncotype DX prostate cancer assay—a clinical RT-PCR assay optimized for prostate needle biopsies;Knezevic;BMC Genomics,2013

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usefulness of Tissue Biomarkers versus Prostate-Specific Membrane Antigen-Positron Emission Tomography for Prostate Cancer Biochemical Recurrence after Radical Prostatectomy;Cancers;2024-08-19

2. Genomic classifiers and prognosis of localized prostate cancer: a systematic review;Prostate Cancer and Prostatic Diseases;2024-01-10

3. High-risk and Oligometastatic Prostate Cancer: Current Treatment Paradigms;UroCancer Clinics of India;2024-01

4. Molecular biomarkers in prostate cancer;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024

5. The Impact of Delayed Radical Prostatectomy on Recurrence Outcomes After Initial Active Surveillance: Results from a Large Institutional Cohort;European Urology Oncology;2023-12